JW Shinyak Corporation (KOSDAQ:067290)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,667.00
+25.00 (1.52%)
Last updated: Jul 9, 2025
0.08%
Market Cap 89.67B
Revenue (ttm) 88.88B
Net Income (ttm) 11.94B
Shares Out 53.22M
EPS (ttm) 223.99
PE Ratio 7.52
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 95,406
Average Volume 140,777
Open 1,659.00
Previous Close 1,642.00
Day's Range 1,570.00 - 1,694.00
52-Week Range 1,220.00 - 2,020.00
Beta 0.84
RSI 53.60
Earnings Date Aug 14, 2025

About JW Shinyak

JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheum... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1981
Employees 197
Stock Exchange KOSDAQ
Ticker Symbol 067290
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.